Wellbeing Digital Sciences Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KONEF research report →
Companywww.ketamine.one
KetamineOne Capital Limited, a next generation wellness company, focuses on ketamine assisted therapy and psychedelic medicines through operating healthcare clinics in North America. The company was formerly known as Myconic Capital Corp. and changed its name to KetamineOne Capital Limited in June 2021.
- CEO
- Najla Guthrie
- IPO
- 2021
- HQ
- Vancouver, BC, CA
Price Chart
Growth & Income
- Revenue
- $6.44M · 469.43%
- Net Income
- $-25,205,741 · 21.02%
- EPS
- $-0.21 · 43.24%
- Op Income
- $-23,781,028
- FCF YoY
- 99.84%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -7.38
- Avg Volume
- 198.08
Get TickerSpark's AI analysis on KONEF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our KONEF Coverage
We haven't published any research on KONEF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate KONEF Report →